Edward Garmey

Edward Garmey has been working in the biopharmaceutical industry since 2014. Edward began their career as a Visiting Instructor in the Therapeutics Graduate Program at Harvard Medical School. In 2018, they founded CMO Consulting, Inc., a team of medical oncology experts providing integrated, strategic, and comprehensive clinical drug development consulting services. In 2019, they began working as a Consultant Chief Medical Officer at ImmuneSensor Therapeutics. In 2020, they took on the same role at Linnaeus Therapeutics. In 2021, they began working as a Consultant Chief Medical Officer at GigaGen Inc and Oncoheroes Biosciences. In 2022, they began working as a Consulting CMO at ModeX Therapeutics Inc and ImmunoMet Therapeutics, Inc., and as an Interim CMO at HiFiBiO Therapeutics.

Edward Garmey received an AB from Harvard University and an M.D. from the Icahn School of Medicine at Mount Sinai.